These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 12101410)
1. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410 [TBL] [Abstract][Full Text] [Related]
2. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952 [TBL] [Abstract][Full Text] [Related]
3. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Grob TJ; Novak U; Maisse C; Barcaroli D; Lüthi AU; Pirnia F; Hügli B; Graber HU; De Laurenzi V; Fey MF; Melino G; Tobler A Cell Death Differ; 2001 Dec; 8(12):1213-23. PubMed ID: 11753569 [TBL] [Abstract][Full Text] [Related]
4. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest. Vossio S; Palescandolo E; Pediconi N; Moretti F; Balsano C; Levrero M; Costanzo A Oncogene; 2002 May; 21(23):3796-803. PubMed ID: 12032848 [TBL] [Abstract][Full Text] [Related]
5. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232 [TBL] [Abstract][Full Text] [Related]
6. MDM2 suppresses p73 function without promoting p73 degradation. Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051 [TBL] [Abstract][Full Text] [Related]
7. Mouse DDA3 gene is a direct transcriptional target of p53 and p73. Hsieh SC; Lo PK; Wang FF Oncogene; 2002 May; 21(19):3050-7. PubMed ID: 12082536 [TBL] [Abstract][Full Text] [Related]
8. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. Stiewe T; Theseling CC; Pützer BM J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800 [TBL] [Abstract][Full Text] [Related]
9. p73 transcriptional activity increases upon cooperation between its spliced forms. Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502 [TBL] [Abstract][Full Text] [Related]
10. The C terminus of p53 family proteins is a cell fate determinant. Harms KL; Chen X Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654 [TBL] [Abstract][Full Text] [Related]
11. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Di Como CJ; Gaiddon C; Prives C Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077 [TBL] [Abstract][Full Text] [Related]
12. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Tomasini R; Seux M; Nowak J; Bontemps C; Carrier A; Dagorn JC; Pébusque MJ; Iovanna JL; Dusetti NJ Oncogene; 2005 Dec; 24(55):8093-104. PubMed ID: 16044147 [TBL] [Abstract][Full Text] [Related]
13. Role of the p53-homologue p73 in E2F1-induced apoptosis. Stiewe T; Pützer BM Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847 [TBL] [Abstract][Full Text] [Related]
14. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. Melino G; Bernassola F; Ranalli M; Yee K; Zong WX; Corazzari M; Knight RA; Green DR; Thompson C; Vousden KH J Biol Chem; 2004 Feb; 279(9):8076-83. PubMed ID: 14634023 [TBL] [Abstract][Full Text] [Related]
15. Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968 [TBL] [Abstract][Full Text] [Related]
16. Promoter specificity and stability control of the p53-related protein p73. Lee CW; La Thangue NB Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630 [TBL] [Abstract][Full Text] [Related]
17. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter. Racek T; Mise N; Li Z; Stoll A; Pützer BM J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237 [TBL] [Abstract][Full Text] [Related]
18. PCAF is a coactivator for p73-mediated transactivation. Zhao LY; Liu Y; Bertos NR; Yang XJ; Liao D Oncogene; 2003 Nov; 22(51):8316-29. PubMed ID: 14614455 [TBL] [Abstract][Full Text] [Related]
19. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line. Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279 [TBL] [Abstract][Full Text] [Related]
20. Quantitative TP73 transcript analysis in hepatocellular carcinomas. Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]